Due to their complexity, biopharmaceuticals require a vast array of testing using orthogonal techniques.
Apr 2, 2007
By:
Jon S. Kauffman, PhD
A tremendous amount of analytical testing is required to support a biopharmaceutical product from discovery, development, and clinical trials, through manufacturing and marketing. Numerous methods are used to fully characterize large molecules because of their complexity—characterizing them is significantly more difficult than it is for small molecules. Biopharmaceuticals are produced via living systems, i.e., E. coli, yeast, or mammalian cells, which require additional testing matrices.
|
